A 36-month Analysis of the Clinical Performance of Individualized CAD/CAM-produced Dental Implants: a Cohort Study
Launched by UNIVERSITY OF SAO PAULO · Aug 26, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of dental implant designed to replace lost teeth. The focus is on how well these customized implants work over a three-year period. Researchers want to know if these implants are safe and effective compared to traditional methods, especially since they can be placed without the need for drilling. The study will involve 12 patients who will have their health and comfort checked at 12, 24, and 36 months after receiving their implants. Key areas of assessment will include the health of the surrounding tissue, how well the implant integrates with the bone, and whether the implants last without problems.
To be eligible for this study, participants must have previously received a personalized dental implant and completed a follow-up after the first year. They should also be available for follow-up visits during the 36-month period. However, individuals who experienced serious complications during the earlier phase, have uncontrolled medical conditions, or cannot attend scheduled visits may not be included. Participants can expect regular check-ins to monitor their progress and overall satisfaction with the new implants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Received a personalized dental implant using the iDENTICAL Dental Implant System during the previous interventional phase;
- • Completed the 12-month follow-up period after implant placement in the previous interventional phase;
- • Available for follow-up evaluations during the 36 months of the observational study.
- Exclusion Criteria:
- • Occurrence of serious complications (implant loss, infection, etc.) during the previous interventional phase;
- • Development of uncontrolled medical conditions during the follow-up period;
- • Inability to attend scheduled follow-up visits;
- • Refusal to participate in the observational study.
About University Of Sao Paulo
The University of São Paulo (USP) is a prestigious public research university located in Brazil, renowned for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USP leverages its extensive academic resources, interdisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking research aimed at improving patient outcomes and addressing critical health challenges. The university's strong emphasis on ethical standards and regulatory compliance ensures that all clinical trials are conducted with the highest integrity, fostering collaboration among researchers, healthcare professionals, and the broader community to enhance scientific discovery and translate findings into practical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
São Paulo, , Brazil
Patients applied
CW
TN
AG
Trial Officials
Giuseppe A Romito, PhD
Principal Investigator
University of Sao Paulo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported